Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients
A completed clinical trial studying the frequency of extra-axial symptoms in Korean patients with Ankylosing Spondylitis; results posted in …
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis [Phase 4]
A Phase 4 trial evaluating the efficacy and safety of a loxoprofen hydrogel patch in patients with ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium
Completed clinical trial assessing work productivity in Ankylosing Spondylitis and Psoriatic Arthritis patients before and after starting ad…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Treat-to-target With Secukinumab in Axial Spondyloarthritis [Phase 4]
A Phase 4 trial update evaluating treat-to-target strategy with secukinumab in axial spondyloarthritis and ankylosing spondylitis is ongoing…
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients [Phase 3]
Phase 3 trial update reports 16-week efficacy and 3-year safety, tolerability, and efficacy of secukinumab in active ankylosing spondylitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Defining Remission With Etanercept in AS in Real Life Clinical Practice
An update on defining remission with etanercept in real-life practice for ankylosing spondylitis, based on completed clinical trial data.
-
FDA approval · 2018-11-29FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., confirming regulatory clearance for an updated product-rel…
-
FDA approval · 2018-10-30FDA Approved: ADALIMUMAB — Original Application (Sandoz Inc)
FDA approved the original application for the adalimumab biosimilar ADALIMUMAB-ADAZ from Sandoz Inc. The approval covers the same indication…
-
FDA approval · 2018-10-16FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2018-10-03FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation. The approval updates the labeling as descr…
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis [Phase 3]
This Phase 3 study evaluated the efficacy and safety of ustekinumab in anti-TNF refractory patients with active radiographic axial spondyloa…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis [Phase 2]
Phase 2 study assessing efficacy and safety of Filgotinib in Ankylosing Spondylitis has completed.
-
FDA approval · 2018-07-25FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved Bayer's supplemental application to add ALEVE GELCAPS (naproxen sodium) as an additional formulation of naproxen products.
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: Fertility Study of Women With Chronic Inflammatory Rheumatism
This clinical trial update describes a fertility study in women with chronic inflammatory rheumatism, including psoriatic arthritis, rheumat…
-
CLINICAL_TRIALS trial_result · 2018-06-18Clinical Trial Update: Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis [Phase 4]
A Phase 4 trial evaluated the effectiveness and safety of etanercept and celecoxib, used alone or in combination, for active ankylosing spon…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of IBI303 in adults with active ankylosing spondylitis.
-
FDA approval · 2018-05-25FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation. The approval pertains to the supplement to…
-
FDA approval · 2018-05-11FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
The FDA approved a supplemental application for ENBREL (etanercept) submitted by Immunex Corporation. The action updates the drug's labeling…
-
FDA approval · 2018-04-30FDA Approved: CELECOXIB — Original Application (Micro Labs Limited)
FDA approved the original generic application for celecoxib from Micro Labs Limited, providing a generic celecoxib option aligned with the r…
-
CLINICAL_TRIALS research · 2018-03-21Clinical Trial Update: Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents
This clinical trial update examines how originator and biosimilar anti-TNF medications are used and how effective they are for rheumatoid ar…
-
FDA approval · 2018-03-20FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Cimzia (certolizumab pegol) filed by UCB, Inc.
-
FDA approval · 2018-03-15FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
FDA approved a supplemental application for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis [Phase 3]
Phase 3 trial comparing BCD-055, a biosimilar infliximab, to Remicade (infliximab) for efficacy and safety in ankylosing spondylitis has com…
-
FDA approval · 2018-02-09FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for SIMPONI (golimumab) submitted by Janssen Biotech, Inc.
-
FDA approval · 2018-01-23FDA Approved: CELECOXIB — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' generic celecoxib as an Original Application (ANDA210071), enabling market entry for this COX-2 in…